2023
Delayed cancer diagnosis in the pregnant patient: navigating a complex medical and ethical dilemma
Revzin M, Solomon N, Langdon J, Czeyda-Pommersheim F, Menias C. Delayed cancer diagnosis in the pregnant patient: navigating a complex medical and ethical dilemma. Abdominal Radiology 2023, 48: 1599-1604. PMID: 36951988, DOI: 10.1007/s00261-023-03860-x.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMelanoma in pregnancy
Czeyda-Pommersheim F, Kluger H, Langdon J, Menias C, VanBuren W, Leventhal J, Baumann R, Revzin M. Melanoma in pregnancy. Abdominal Radiology 2023, 48: 1740-1751. PMID: 36719425, DOI: 10.1007/s00261-022-03796-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThyroid cancer in pregnancy: diagnosis, management, and treatment
Langdon J, Gupta A, Sharbidre K, Czeyda-Pommersheim F, Revzin M. Thyroid cancer in pregnancy: diagnosis, management, and treatment. Abdominal Radiology 2023, 48: 1724-1739. PMID: 36719426, DOI: 10.1007/s00261-023-03808-1.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsThyroid cancerRadioactive iodine exposureNon-pregnant patientsRole of CTUnique clinical challengesManagement of cancerSurgical interventionClinical challengePregnancyIodine exposureRadioactive iodineThyroid nodulesCancerFetusesNuclear imagingRadiologist's perspectiveTreatmentDiagnosisCareMothersRiskImagingManagementPatientsPrognosis
2021
Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?
Guo Y, Czeyda-Pommersheim F, Miccio JA, Mahalingam S, Cecchini M, Pahade J. Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection? Abdominal Radiology 2021, 46: 5609-5617. PMID: 34557934, DOI: 10.1007/s00261-021-03284-5.Peer-Reviewed Original ResearchConceptsSubsequent R0 resectionOverall survivalR0 resectionNeoadjuvant therapyPancreatic ductal adenocarcinomaImaging responseMultivariable Cox proportional hazards analysisCox proportional hazards analysisPostoperative CA19-9Median overall survivalImproved diseaseProportional hazards analysisKaplan-Meier analysisSimilar diseasesPatient ageVascular involvementClinical stagingMethodsRetrospective analysisPredict SurvivalClinical parametersPDAC patientsCA 19CA19-9Mean ageCancer patients
2020
Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know
Czeyda-Pommersheim F, Menias C, Boustani A, Revzin M. Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know. Abdominal Radiology 2020, 46: 1062-1081. PMID: 32944824, DOI: 10.1007/s00261-020-02752-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsAssessing the Impact of Referral on Multidisciplinary Tumor Board Outcomes in Patients With Hepatocellular Carcinoma
Zhang Y, Weinreb J, Czeyda-Pommersheim F, Taddei T. Assessing the Impact of Referral on Multidisciplinary Tumor Board Outcomes in Patients With Hepatocellular Carcinoma. Journal Of The American College Of Radiology 2020, 17: 1636-1643. PMID: 32533924, DOI: 10.1016/j.jacr.2020.05.003.Peer-Reviewed Original ResearchConceptsMultidisciplinary liver tumor boardTertiary care institutionHepatocellular carcinomaImpact of referralHCC casesCare institutionsInitial suspicionDecreased health care costsDiagnosis of HCCIncident HCC casesUnnecessary diagnostic proceduresHealth care costsChart reviewConsensus of expertsInitial careOptimal treatmentTumor boardAmerican CollegeHCC diagnosisPatientsUnique cancerCare costsOutside institutionDiagnostic proceduresReferral
2017
Contrast Agents for MR Imaging
Czeyda-Pommersheim F, Martin DR, Costello JR, Kalb B. Contrast Agents for MR Imaging. Magnetic Resonance Imaging Clinics Of North America 2017, 25: 705-711. PMID: 28964460, DOI: 10.1016/j.mric.2017.06.011.ChaptersConceptsAdverse eventsContrast mediumMR imagingCommon adverse eventsOral MR contrast agentGadolinium-based contrastContrast agentsOral contrast agentSpecific clinical questionsExcellent safety recordCT contrast mediaIron-based agentVariety of agentsLower incidenceClinical questionsSpecific contrast agentsClinical useMR contrast agentsSafety recordAgentsImagingIncidencePharmacology
2016
MRI in pelvic inflammatory disease: a pictorial review
Czeyda-Pommersheim F, Kalb B, Costello J, Liau J, Meshksar A, Arif Tiwari H, Martin D. MRI in pelvic inflammatory disease: a pictorial review. Abdominal Radiology 2016, 42: 935-950. PMID: 27933478, DOI: 10.1007/s00261-016-1004-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPelvic inflammatory diseaseInflammatory diseasesAcute pelvic inflammatory diseaseSubclinical pelvic inflammatory diseaseCommon causative organismReproductive-age womenPelvic soft tissuesFemale genital tractSuperior soft tissue contrastAbdominal painAcute complicationsChronic sequelaeMRI findingsClinical presentationUreteral obstructionAge womenGenital tractInclusion cystsCommon causePictorial reviewCausative organismCorrect diagnosisSpread of bacteriaSoft tissue contrastSoft tissueMRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability
Petkovska I, Duke E, Martin DR, Irani Z, Geffre CP, Cragun JM, Costello JR, Arif-Tiwari H, Czeyda-Pommersheim F, Udayasankar U, Kalb B. MRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability. European Journal Of Radiology 2016, 85: 2064-2071. PMID: 27776660, DOI: 10.1016/j.ejrad.2016.09.020.Peer-Reviewed Original ResearchConceptsT2-hypointense rimOvarian viabilityOvarian torsionPerifollicular hemorrhagePredictive valueEmergency department noteNegative predictive valuePositive predictive valueTorsed ovaryRetrospective studyHypointense rimPreoperative MRIDiagnostic considerationsHistological examT2 hypointenseHemorrhageHistopathologic examPatientsLevel of agreementMRIUseful predictorDetorsionHistology
2015
Amyloidosis: Modern Cross-sectional Imaging
Czeyda-Pommersheim F, Hwang M, Chen SS, Strollo D, Fuhrman C, Bhalla S. Amyloidosis: Modern Cross-sectional Imaging. RadioGraphics 2015, 35: 1381-92. PMID: 26230754, DOI: 10.1148/rg.2015140179.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCardiac magnetic resonance imagingMultiple parenchymal nodulesPrognosis of amyloidosisHilar lymph nodesModern cross-sectional imagingMultiple organ systemsCross-sectional imagingMagnetic resonance imagingLeft ventricular wallAirway thickeningSubmucosal calcificationsLung involvementPleural involvementAirway obstructionDiastolic dysfunctionInterstitial thickeningLymph nodesPrimary diseasePleural effusionRadiologic manifestationsTracheobronchial involvementChronic infectionDiagnostic challengeIntraluminal nodulesParenchymal nodules
2013
Free-Breathing, Motion-Corrected Late Gadolinium Enhancement Is Robust and Extends Risk Stratification to Vulnerable Patients
Piehler K, Wong T, Puntil K, Zareba K, Lin K, Harris D, Deible C, Lacomis J, Czeyda-Pommersheim F, Cook S, Kellman P, Schelbert E. Free-Breathing, Motion-Corrected Late Gadolinium Enhancement Is Robust and Extends Risk Stratification to Vulnerable Patients. Circulation Cardiovascular Imaging 2013, 6: 423-432. PMID: 23599309, PMCID: PMC4066466, DOI: 10.1161/circimaging.112.000022.Peer-Reviewed Original ResearchAdultAgedArtifactsBreath HoldingCardiac-Gated Imaging TechniquesChi-Square DistributionContrast MediaDisease ProgressionFemaleGadoliniumHeart FailureHeterocyclic CompoundsHospitalizationHumansImage Interpretation, Computer-AssistedLinear ModelsLogistic ModelsMagnetic Resonance Imaging, CineMaleMiddle AgedMyocardial InfarctionMyocardiumOdds RatioOrganometallic CompoundsPredictive Value of TestsPrognosisProportional Hazards ModelsProspective StudiesRespirationRisk FactorsTime Factors
2006
Repeat Uterine Artery Embolization: Indications and Technical Findings
Yousefi S, Czeyda-Pommersheim F, White A, Banovac F, Hahn W, Spies J. Repeat Uterine Artery Embolization: Indications and Technical Findings. Journal Of Vascular And Interventional Radiology 2006, 17: 1923-1929. PMID: 17185687, DOI: 10.1097/01.rvi.0000244851.04692.b5.Peer-Reviewed Original ResearchConceptsUterine artery embolizationRepeat embolizationArtery embolizationNew tumorsOvarian artery embolizationMagnetic resonanceBulk symptomsInitial embolizationPelvic painSymptom controlFirst embolizationPersistent symptomsSecond embolizationIncomplete infarctionSingle centerAngiographic studiesCommon symptomsHeavy bleedingTumor infarctionEmbolization studiesUterine leiomyomaEmbolizationPatientsTumorsSymptomsVenous Thromboembolism After Uterine Fibroid Embolization
Czeyda-Pommersheim F, Magee S, Cooper C, Hahn W, Spies J. Venous Thromboembolism After Uterine Fibroid Embolization. CardioVascular And Interventional Radiology 2006, 29: 1136-1140. PMID: 16810461, DOI: 10.1007/s00270-005-0245-3.Peer-Reviewed Original Research
2005
Long-Term Outcome of Uterine Artery Embolization of Leiomyomata
Spies J, Bruno J, Czeyda-Pommersheim F, Magee S, Ascher S, Jha R. Long-Term Outcome of Uterine Artery Embolization of Leiomyomata. Obstetrics And Gynecology 2005, 106: 933-939. PMID: 16260509, DOI: 10.1097/01.aog.0000182582.64088.84.Peer-Reviewed Original ResearchConceptsUterine artery embolizationFinal followSymptom controlArtery embolizationUterine embolizationCox proportional hazards modelDurable symptom reliefLeiomyoma volume reductionPatient's final followLong-term outcomesProportional hazards modelSubsequent hysterectomyBaseline characteristicsFirst tertileMost patientsRepeat embolizationThird tertileConsecutive patientsMenstrual statusSymptom reliefTerm outcomesLeiomyoma volumeProspective studySymptom improvementSymptom status